Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-05-000005
Filing Date
2005-01-05
Accepted
2005-01-05 19:33:36
Documents
1
Period of Report
2005-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6378
  Complete submission text file 0000891293-05-000005.txt   8139
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 ELLIOT AVENUE WEST SUITE 400 SEATTLE WA 98119
Business Address
CANFIELD JAMES (Reporting) CIK: 0001204261 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 05514252